Chemcorp Pty Ltd. – Trademark Portfolio
Entity Type: 03
Chemcorp Pty Ltd. has 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include BATHEFEX and 1000 HOUR. The portfolio includes 2 registered trademarks. Filings span 7 Nice Classification classes, led by Class 26 (Fancy Goods) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in Taren Point.
7 Box Road
Taren Point 2229 , AU
Showing of trademarks Trademarks
Trademark Classifications
Chemcorp Pty Ltd.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Chemcorp Pty Ltd. have?
Chemcorp Pty Ltd. has 27 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 abandoned, 15 cancelled.
What trademark classes does Chemcorp Pty Ltd. file in?
Chemcorp Pty Ltd. files trademarks across 7 Nice Classification classes. The most active classes are Class 26 (Fancy Goods), Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 16 (Paper Goods), Class 8 (Hand Tools). Class 26 covers lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles.
What are Chemcorp Pty Ltd.'s most well-known trademarks?
Chemcorp Pty Ltd.'s registered trademark portfolio includes well-known marks such as BATHEFEX and 1000 HOUR. These are among 2 currently registered trademarks in the portfolio.
What is Chemcorp Pty Ltd.'s trademark registration success rate?
Chemcorp Pty Ltd. has a 7% trademark registration rate, with 2 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.